Back

The diagnostic efficacy of the ajmaline challenge in SCN5A positive Brugada syndrome patients

31 March 2025 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: Primary arrhythmias syndromes and sudden cardiac death Diagnostic Methods EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Thomas Rosseel

Hospital Clinic, University of Barcelona, Barcelona (Spain)

3 More presentations in this session

Presentation thumbnail
Static and dynamic abnormalities in electromechanical and autonomic cardiac function characterize the proarrhythmic substrate in the long-QT syndrome
Doctor P. Deissler (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Premature ventricular complexes in survivors of idiopathic ventricular fibrillation: short-coupled near major arrhythmic events, but longer-coupled remotely
Doctor J. Stoks (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Non-pharmacological early detection of concealed Brugada syndrome via basal ECG analysis
Doctor E. Calvi (Brescia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Primary arrhythmias syndromes and sudden cardiac death

The Event

Event poster

EHRA 2025

31 March 2025 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Genetic variants associated with ventricular arrhythmias during ajmaline test in Brugada syndrome
thumbnail
Congress Presentation
Ajmaline testing in Brugada Syndrome: a comparative analysis of diagnostic protocols and clinical outcomes across two hospital centers
thumbnail
Congress Presentation
Safety profile of ajmaline testing in Brugada syndrome: influence of SCNA5 mutations

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources